Impact of the stepwise approach to cardiovascular disease prevention in patients with established ASCVD from the 2021 ESC Prevention Guideline

Back

ESC Professional Premium Access

Impact of the stepwise approach to cardiovascular disease prevention in patients with established ASCVD from the 2021 ESC Prevention Guideline

Session: Secondary prevention

Topic: Secondary Prevention

Speaker: Mr J. Holtrop (Utrecht, NL)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Mr Joris Holtrop

University Medical Center Utrecht, Utrecht (Netherlands (The))

0 follower

8 more presentations in this session

Real world prognostic impact and predictors of adherence to statin therapy after STEMI on first year follow up: results from the FAST STEMI registry

Speaker: Doctor L. Carmagnola (Turin, IT)

Long-term aspirin adherence and risk of cardiovascular events and death after myocardial infarction: A nationwide cohort study

Speaker: Doctor A. Kristensen (Frederiksberg, DK)

A global perspective on cardiovascular risk factor management in patients with CHD and different educational level: SURF CHD II

Speaker: Ms A. Marza Florensa (Utrecht, NL)

Lower income is associated with non-persistence to statin treatment after a first myocardial infarction

Speaker: Mr K. Ma (Stockholm, SE)

Lipid assessment and achievement of secondary prevention european society of cardiology guideline targets in patients with atherosclerotic cardiovascular disease with and without depression

Speaker: Doctor R. Summers (Swansea, GB)

Access the full session

Secondary prevention

Speakers: Mr J. Holtrop, Doctor L. Carmagnola, Doctor A. Kristensen, Ms A. Marza Florensa, Mr K. Ma...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources